Professional
Added to YB: 2025-07-03
Pitch date: 2025-06-30
CRGX [neutral]
CARGO Therapeutics, Inc.
+9.29%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, focused on designing, engineering, and developing potentially curative cell therapies for cancer patients in the United States.
Market Cap
$215.7M
Pitch Price
$4.09
Price Target
5.00 (+12%)
Dividend
N/A
EV/EBITDA
0.32
P/E
-0.96
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Clark Street Value Mid Year 2025 Portfolio Review: Current Position - CARGO Therapeutics, Inc.
CRGX (holding update): Waived white flag 3/18, 90% layoffs, suspended all drug development, appointed CEO for strategic alternatives. Trades at $4.14 vs <$5 liquidation value ($235MM, attractive for merger partners). Madison Avenue Partners and Kevin Tang each own ~6.5%.
Read full article (1 min)